Published on GHDx (https://ghdx.healthdata.org)

Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic

General Info

Geography 
Netherlands (NLD)
Coverage type 
Country
Time period covered 
January, 2018 - December, 2020
Data type
Scientific literature
Keywords 
Breast cancer, COVID-19, Cancers

Citation

Authors 
Eijkelboom AH, de Munck L, Lobbes MBI, van Gils CH, Wesseling J, Westenend PJ, Guerrero Paez C, Pijnappel RM, Verkooijen HM, Broeders MJM, Siesling S, NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium
Journal 
Prev Med
Pages 
106602
Publication year 
2021
Suggested citation 
Eijkelboom AH, de Munck L, Lobbes MBI, van Gils CH, Wesseling J, Westenend PJ, Guerrero Paez C, Pijnappel RM, Verkooijen HM, Broeders MJM, Siesling S, NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium. Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic. Prev Med. 2021; 151: 106602.
Source URL:https://ghdx.healthdata.org/record/impact-suspension-and-restart-dutch-breast-cancer-screening-program-breast-cancer-incidence#comment-0